Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Aurélie Millier"'
Autor:
Claire Leboucher, Cécile Blein, Valérie Machuron, Kelly Benyounes, Katell Le lay, Aurélie Millier, Romain Supiot, François Raffi
Publikováno v:
Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
ABSTRACTBackground The economic consequences of the recent COVID-19 pandemic were substantial. However, direct medical costs in France have not been determined.Objective To describe patient characteristics, intensity of care, mortality, and direct me
Externí odkaz:
https://doaj.org/article/15497970cafa464081617ec53bd8ae24
Autor:
Aurélie Millier, Romain Supiot, Kelly Benyounes, Valérie Machuron, Katell Le Lay, Marine Sivignon, Claire Leboucher, Cécile Blein, François Raffi
Publikováno v:
Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)
Background Quantification of COVID-19 burden may be useful to support the future allocation of resources.Objective To evaluate the public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.Study d
Externí odkaz:
https://doaj.org/article/127e431a65e14202bacc9742e0797ce4
Autor:
Carlos Escobar Cervantes, Julio Martí-Almor, Alejandro Isidoro Pérez Cabeza, Kevin Bowrin, Aleix Llorac Moix, Mar Genís Gironès, David Gasche, Aurélie Millier, Jean Tardu, Mondher Toumi, Jean-Baptiste Briere
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0266658 (2022)
AimsA Markov model was adapted to assess the real-world cost-effectiveness of rivaroxaban, dabigatran and apixaban. Each of these non-vitamin K antagonist oral anticoagulants was compared with vitamin K antagonist for stroke prevention in patients wi
Externí odkaz:
https://doaj.org/article/eb092c35bbd84ed6aa5885bab357e8be
Autor:
Mondher Toumi, Aurélie Millier, Olivier Cristeau, Katia Thokagevistk-Desroziers, Julie Dorey, Samuel Aballéa
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Objectives: While several authors have suggested using a multi-criteria approach for orphan drug assessment and proposed lists of determinants of orphan drug value, studies on social preferences regarding these determinants remain limited. The curren
Externí odkaz:
https://doaj.org/article/d3ad0261ae8847a59e9c0abc3e11e490
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Background Morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) imposes a substantial economic burden on the UK healthcare system. Objectives An existing Markov model was adapted to assess the real-world cost-effectiveness
Externí odkaz:
https://doaj.org/article/5e95112410e74f1183cf795e93f044e3
Autor:
Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma, Mondher Toumi
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Objective: To provide recommendations for addressing previously identified key challenges in health economic evaluations of Gene Replacement Therapies (GRTs), including: 1) the assessment of clinical effectiveness; 2) the valuation of health outcomes
Externí odkaz:
https://doaj.org/article/94468d6f449f4f42bffe48594a3cb1c3
Autor:
Kevin Bowrin, Jean-Baptiste Briere, Laurent Fauchier, Craig Coleman, Aurélie Millier, Mondher Toumi, Emilie Clay, Pierre Levy
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0225301 (2020)
OBJECTIVE:The objective was to assess the real-world cost-effectiveness of rivaroxaban, versus vitamin K antagonists (VKAs), for stroke prevention in patients with atrial fibrillation (AF) from a French national health insurance perspective. METHODS:
Externí odkaz:
https://doaj.org/article/8513bdea822c4f258201969642d1647f
Autor:
Craig I. Coleman, Jean-Baptiste Briere, Laurent Fauchier, Pierre Levy, Kevin Bowrin, Mondher Toumi, Aurélie Millier, Vanessa Taieb, Olivia Wu
Publikováno v:
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Introduction: Numerous real-world studies have compared non-vitamin K antagonist oral anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF). A meta-analysis was performed to synthesize the a
Externí odkaz:
https://doaj.org/article/2a8f043b0a824dbaa571cb468c552b94
Publikováno v:
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background and Objectives: Utility elicitation studies for schizophrenia generate different utility values for the same health states. We reviewed utility values used in schizophrenia pharmacoeconomic evaluations and evaluated the impact of their sel
Externí odkaz:
https://doaj.org/article/27d7feb093ab47c0b633671d55a98956
Autor:
Chiraz Azaiez, Aurélie Millier, Christophe Lançon, Emilie Clay, Pascal Auquier, Pierre-Michel Llorca, Mondher Toumi
Publikováno v:
Journal of Market Access & Health Policy, Vol 6, Iss 1 (2018)
Background: Schizophrenia negative symptoms (SNS) contribute substantially to poor functional outcomes, loss in productivity and poor quality of life. It is unclear which instruments may be used for assessing quality of life in patients with SNS. Obj
Externí odkaz:
https://doaj.org/article/7d0af0d116ce47808a14d52619811e7e